denileukin diftitox trade name ontak antineoplastic agent engineered protein combining diphtheria toxin denileukin diftitox could bind introduce diphtheria toxin cells express receptors killing cells leukemias lymphomas malignant cells express receptors denileukin diftitox target ontak approved us food drug administration fda treatment cutaneous tcell lymphoma evidence tying vision loss fda added black box warning drugs marketing ontak discontinued antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikidenileukindiftitox